ALT LAKE CITY, Jul 8, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Gary A. King has joined the Company in the newly created position of Executive Vice President of International Operations.
"It is with a great deal of pleasure that I welcome Gary to the Myriad team," said Peter D. Meldrum, President and Chief Executive Officer. "Gary is a talented and seasoned executive, whose strong international experience in the healthcare industry will serve Myriad well as we advance our goal of building a significant presence in Europe by the end of 2012."
Mr. King, 54, will oversee all aspects of the Company's expansion into Europe and other international markets, including operations, sales and marketing, regulatory approval, and pricing and reimbursement. He will refine and execute the Company's international strategy on a country-by-country basis, initially focusing on the major market countries of Germany, France, Italy, Spain, and the United Kingdom. Mr. King will also initiate marketing plans in Europe for the Company's eight molecular diagnostic products.
Mr. King has been employed in the life sciences industry for more than 25 years. Most recently he was the Chief Executive Officer of AverDx Incorporated, an international biotechnology company that develops novel biomarker diagnostics for critical diseases. Prior to AverDx, he was Vice President, International Operations at Biosite Incorporated, a developer of diagnostic products and antibody development technologies where he spent six years building and leading all of the company's commercial activities outside the United States. He established marketing and logistics operations in Germany, France, Italy, the United Kingdom, Netherlands, and Belgium, and he established clinical operations and marketing programs in Asia. Prior to joining Biosite, Mr. King was Division Director in Japan for Guidant Corporation and led Guidant's transition from distributor to direct operations in the Japanese market. Mr. King received his Bachelor of Arts degree in Zoology from Pomona College and a Masters of Business Administration degree from Stanford University.